Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · Real-Time Price · USD
0.7270
-0.0230 (-3.07%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Ironwood Pharmaceuticals Employees
Ironwood Pharmaceuticals had 253 employees as of December 31, 2024. The number of employees decreased by 14 or -5.24% compared to the previous year.
Employees
253
Change (1Y)
-14
Growth (1Y)
-5.24%
Revenue / Employee
$1,388,972
Profits / Employee
$3,478
Market Cap
117.59M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
IRWD News
- 4 days ago - Ironwood Pharmaceuticals Stock Plunges, FDA Wants Another Trial For Gastrointestinal Drug - Benzinga
- 4 days ago - Ironwood Pharmaceuticals Provides Clinical and Regulatory Update on Apraglutide - Business Wire
- 8 days ago - Ironwood Pharmaceuticals: Setting A Strong Foundation For A Return To Growth - Seeking Alpha
- 22 days ago - Ironwood Pharmaceuticals Announces Receipt of Nasdaq Non-Compliance Notification Regarding Late 2024 Form 10-K Filing - Business Wire
- 24 days ago - Industry Veteran Launches Ironwood III With Substantial Equity Commitment From Kayne Anderson Energy Infrastructure Fund - Business Wire
- 7 weeks ago - Ironwood Pharmaceuticals, Inc. (IRWD) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results; Achieves 2024 Financial Guidance - Business Wire
- 2 months ago - Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Investor Update Call - Business Wire